Bardoxolone methyl improves survival and reduces clinical measures of kidney injury in tumor-bearing mice treated with cisplatin

Abstract Objective Acute kidney injury (AKI) occurs in approximately one-third of patients treated with cisplatin and there is an outstanding need for mitigation strategies to decrease the frequency and severity of cisplatin-induced AKI. This study evaluated bardoxolone methyl (BARD) as a nephroprot...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Lauren E. Thompson, Stacey M. Tuey, Paola Garcia Gonzalez, Carly S. Chesterman, Courtney D. McGinnis, M. Scott Lucia, Lauren M. Aleksunes, Charles L. Edelstein, Melanie S. Joy
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	SpringerOpen 2025-03-01
Edice:	AAPS Open
Témata:	Cisplatin Nephrotoxicity Bardoxolone Methyl Acute Kidney Injury Nrf2
On-line přístup:	https://doi.org/10.1186/s41120-025-00107-5
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!